KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	131.62	31.79	56.24	30.73	50.59
Short-Term Investments	89	178.61	93.14	135.47	198.34
Cash & Short-Term Investments	220.62	210.4	149.38	166.2	248.93
Cash Growth	4.86%	40.85%	-10.12%	-33.23%	267.62%
Accounts Receivable	11	-	-	-	-
Other Receivables	4.14	10.87	18.64	16.81	11.72
Receivables	15.14	10.87	18.64	16.81	11.72
Prepaid Expenses	5.93	4.42	4.31	10.64	3.62
Total Current Assets	241.69	225.69	172.33	193.65	264.26
Property, Plant & Equipment	7.53	9.15	10.77	10.04	7.55
Other Long-Term Assets	1.55	0.57	0.11	0.19	0.2
Total Assets	250.77	235.4	183.2	203.88	272.01
Accounts Payable	4.88	9.11	4.82	3.64	1.98
Accrued Expenses	27.31	12.4	9.13	6.96	6.93
Current Portion of Leases	1.98	1.3	1.09	0.98	0.86
Current Unearned Revenue	11	-	-	-	-
Total Current Liabilities	45.17	22.81	15.03	11.58	9.77
Long-Term Debt	105.88	-	-	-	-
Long-Term Leases	4.33	6.02	7.15	7.21	5.05
Total Liabilities	155.38	28.82	22.18	18.79	14.82
Common Stock	0.05	0.04	0.03	0.03	0.02
Additional Paid-In Capital	753.73	679.75	507.13	439.1	426.44
Retained Earnings	-653.17	-469.73	-343.08	-250.18	-167.84
Comprehensive Income & Other	-5.21	-3.49	-3.06	-3.86	-1.43
Total Common Equity	95.39	206.58	161.03	185.09	257.19
Shareholders' Equity	95.39	206.58	161.03	185.09	257.19
Total Liabilities & Equity	250.77	235.4	183.2	203.88	272.01
Total Debt	112.19	7.32	8.23	8.19	5.91
Net Cash (Debt)	108.43	203.08	141.14	158.01	243.02
Net Cash Growth	-46.61%	43.89%	-10.68%	-34.98%	267.83%
Net Cash Per Share	2.18	5.52	5.06	6.46	12.73
Filing Date Shares Outstanding	49.95	42.74	34.23	24.57	24.44
Total Common Shares Outstanding	49.76	42.52	34.17	24.55	24.42
Working Capital	196.52	202.88	157.29	182.07	254.49
Book Value Per Share	1.92	4.86	4.71	7.54	10.53
Tangible Book Value	95.39	206.58	161.03	185.09	257.19
Tangible Book Value Per Share	1.92	4.86	4.71	7.54	10.53
Machinery	3.64	3.08	3.05	2.6	2.01
Leasehold Improvements	3.09	2.86	2.86	2	1.87

Updated Jul 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q